Cysteamine
CAS No. 60-23-1
Cysteamine ( β-MEA;β-Mercaptoethylamine;Decarboxycysteine;MEA;Thioethanolamine )
Catalog No. M15246 CAS No. 60-23-1
An agent for the treatment of nephropathic cystinosis and an antioxidant.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 45 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCysteamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn agent for the treatment of nephropathic cystinosis and an antioxidant.
-
DescriptionAn agent for the treatment of nephropathic cystinosis and an antioxidant; increases intracellular glutathione levels in cystinotic cells, also increases the rates of apoptosis in cystinotic cells; is an excellent scavenger of OH and HOCl and also reacts with H2O2; significantly increase the intracellular GSH levels; also causes autophagosome accumulation in cancer cells.Other Indication Approved
-
Synonymsβ-MEA;β-Mercaptoethylamine;Decarboxycysteine;MEA;Thioethanolamine
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorCystine;NPYR2;SomatostatinReceptor
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number60-23-1
-
Formula Weight77.15
-
Molecular FormulaC2H7NS
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESNCCS
-
Chemical NameEthanethiol, 2-amino-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Besouw, M, et al. Drug Discov Today, 2013. 18(15-16): p. 785-92.
2. de Matos, D.G, et al. Mol Reprod Dev, 1995. 42(4): p. 432-6.
3. Wan XM, et al. Int J Cancer. 2011 Sep 1;129(5):1087-95.
2. de Matos, D.G, et al. Mol Reprod Dev, 1995. 42(4): p. 432-6.
3. Wan XM, et al. Int J Cancer. 2011 Sep 1;129(5):1087-95.
molnova catalog
related products
-
DMXAA
A vascular disrupting agent (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 uM; activates STING dependent innate immune pathways.
-
ULK-101
ULK-101 suppresses autophagy induction and autophagic flux in response to different stimuli.
-
Glycycoumarin
Glycycoumarin is an estrogen agonist, it shows moderate inhibitory effects against CYP1A2 and CYP2B6.